Coditussin DAC (Glendale Inc)


Welcome to the PulseAid listing for the Coditussin DAC drug offered from Glendale Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Glendale Inc
NON-PROPRIETARY NAME: CODEINE PHOSPHATE, GUAIFENESIN, and PSEUDOEPHEDRINE HYDROCHLORIDE
SUBSTANCE NAME: CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: SYRUP
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2016-05-01
END MARKETING DATE: 0000-00-00


Coditussin DAC HUMAN OTC DRUG Details:

Item DescriptionCoditussin DAC from Glendale Inc
LABELER NAME: Glendale Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 10; 200; 30(mg/5mL; mg/5mL; mg/5mL)
START MARKETING DATE: 2016-05-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70147-414_5a3c4507-724c-4145-8d32-be791e9c6fa4
PRODUCT NDC: 70147-414
APPLICATION NUMBER: part341

Other CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Glendale IncCoditussin DAC
Llorens Pharmaceutical International DivisionTusnel
Respa Pharmaceuticals, Inc.Tricode
Sallus Laboratories, LLCLORTUSS
Virtus PharmaceuticalsVirtussin DAC